- Home
- JAZZ vs CHX Comparison
JAZZ vs CHX Comparison
Compare JAZZ & CHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- CHX
- Stock Information
- Founded
- JAZZ 2003
- CHX 1882
- Country
- JAZZ Ireland
- CHX United States
- Employees
- JAZZ N/A
- CHX 7100
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- CHX Industrial Machinery/Components
- Sector
- JAZZ Health Care
- CHX Industrials
- Exchange
- JAZZ Nasdaq
- CHX Nasdaq
- Market Cap
- JAZZ 6.5B
- CHX 5.2B
- IPO Year
- JAZZ 2007
- CHX N/A
- Fundamental
- Price
- JAZZ $122.49
- CHX $27.54
- Analyst Decision
- JAZZ Buy
- CHX Buy
- Analyst Count
- JAZZ 14
- CHX 4
- Target Price
- JAZZ $173.93
- CHX $39.00
- AVG Volume (30 Days)
- JAZZ 539.6K
- CHX 1.6M
- Earning Date
- JAZZ 11-06-2024
- CHX 02-03-2025
- Dividend Yield
- JAZZ N/A
- CHX 1.34%
- EPS Growth
- JAZZ 458.10
- CHX 7.15
- EPS
- JAZZ 7.04
- CHX 1.62
- Revenue
- JAZZ $3,992,712,000.00
- CHX $3,665,501,000.00
- Revenue This Year
- JAZZ $7.51
- CHX N/A
- Revenue Next Year
- JAZZ $6.82
- CHX $3.98
- P/E Ratio
- JAZZ $17.38
- CHX $17.00
- Revenue Growth
- JAZZ 5.23
- CHX N/A
- 52 Week Low
- JAZZ $99.06
- CHX $25.46
- 52 Week High
- JAZZ $134.17
- CHX $39.95
- Technical
- Relative Strength Index (RSI)
- JAZZ 53.16
- CHX 29.45
- Support Level
- JAZZ $121.22
- CHX $28.66
- Resistance Level
- JAZZ $126.23
- CHX $29.69
- Average True Range (ATR)
- JAZZ 2.83
- CHX 0.68
- MACD
- JAZZ -0.23
- CHX -0.27
- Stochastic Oscillator
- JAZZ 50.43
- CHX 3.95
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About CHX ChampionX Corporation
ChampionX provides chemical solutions and equipment for onshore and offshore oil and gas production. Its engineering expertise spans the well lifecycle, but the firm maintains a particular focus on the production phase. Key offerings include artificial lift services and drilling technologies, specializing in polycrystalline diamond cutter inserts. ChampionX was formed after Apergy acquired its chemical technologies business from Ecolab in 2020.